APLT Investing in Applied Therapeutics (APLT) may seem risky at first glance, but there are several potential reasons that attract bold investors:🎯 1. Focus on Rare Diseases
- The company is developing treatments for conditions such as galactosemia, a rare genetic disorder.
- The market for orphan therapies is often supported by favorable regulations and high pricing.
🚀 2. Possible Growth Potential
- The stock trades at a very low price (under $1 USD), which creates the opportunity for a significant rally if good news emerges.
- If it receives FDA approvals or makes progress in clinical trials, the price could skyrocket.
🧬 3. Promising Pipeline
- The products under development target several serious diseases.
- Any of them could become a major catalyst for the stock price.
💼 4. Acquisition or Partnership
- Large biopharmaceutical companies often look for innovative startups. Applied Therapeutics could become an acquisition target.
